|
N.J.A.C.
7:28-24 NUCLEAR MEDICINE TECHNOLOGY
Adopted April
17,2000.
This
is an unofficial version
The official
version can be found in the April 17, 2000
New Jersey Register or from Westlaw Publishing
N.J.A.C.
7:28-24 NUCLEAR MEDICINE TECHNOLOGY
7:28-24.1
Purpose, scope and applicability
(a) This subchapter establishes
educational and licensure requirements, as well as delineating the
scope of practice for persons engaged in the practice of nuclear medicine
technology. This subchapter further establishes certain responsibilities
of authorized medical users, owners, and registrants of radiation
sources used in the practice of nuclear medicine technology. This
subchapter also establishes standards for the operation of, and the
Department's approval of, educational programs in nuclear medicine
technology.
(b) This subchapter
shall not be interpreted as precluding persons specializing in nuclear
medicine physics, computer science, or engineering from manipulating
data under the supervision of an authorized medical user.
(c) The following are
exempt from the requirement to possess a nuclear medicine technology
license:
1. Authorized medical
users;
2. Hospital residents,
hospital interns or hospital fellows specializing in nuclear medicine,
who are under the direction of an authorized medical user;
3. Hospital residents,
hospital interns or hospital fellows involved in nuclear medicine
procedures but not specializing therein, provided that
they are acting under the direct supervision of either an authorized
medical user or a licensed nuclear medicine technologist who is
under the direction of an authorized medical user;
4. Students enrolled in
and attending a school or college of medicine or osteopathy, who
are acting within the school's curriculum, provided that students
are under the direct supervision of either an authorized medical
user or a licensed nuclear medicine technologist who is under
the direction of an authorized medical user; and
5. Students enrolled in
and attending a school of nuclear medicine technology, who are
acting within the school's approved curriculum, provided that
such students are identified on the student list filed by the
school with the Department, and are acting in a clinical affiliation
approved by the Department, upon the recommendation of the Commission,
and are under the direct or immediate supervision of either an
authorized medical user or a licensed nuclear medicine technologist
who is under the direction of an authorized medical user.
(d) The requirements
of this subchapter shall not apply to a licensed radiopharmacy operating
within the scope of its Department radioactive materials license,
New Jersey Board of Pharmacy license, and Nuclear Regulatory Commission
license.
(e) The provisions
of this subchapter do not apply to the therapeutic use of sealed sources
of ionizing radiation.
7:28-24.2 Definitions
The following words
and terms, when used in this subchapter, shall have the following
meanings unless the context clearly indicates otherwise.
"Authorized
medical user" means, a licensed physician who is identified as
an authorized user on a Department radioactive materials license that
authorizes the medical use of naturally occurring or accelerator produced
radioactive materials or on a Nuclear Regulatory Commission license
that authorizes the medical use of by-product materials.
"Diagnostic
dose" means a radionuclide or radiopharmaceutical which is intended
for diagnostic purposes.
"Direct Supervision"
means guidance, direction and instruction by an authorized medical
user or licensed nuclear medicine technologist who is personally aware
of, and maintains independent professional responsibility for, the
procedure intended for a given patient, and is present in the facility
and is available for immediate assistance.
"Immediate supervision"
means in-room presence for instruction, direction and guidance by
an authorized medical user or a licensed nuclear medicine technologist,
who is available to assume control of the given procedure.
"Initial
Application" means the first application submitted by an individual
to the Department for a license to practice nuclear medicine technology.
"Licensed
Nuclear Medicine Technologist" (LNMT) means a person who possesses
a valid license issued by the Department to engage in the practice
of nuclear medicine technology.
"Licensed
Physician" means an individual who holds a plenary license to
practice medicine issued by the New Jersey State Board of Medical
Examiners.
"Practice
of Nuclear Medicine Technology" means preparing radiopharmaceuticals
for administration to humans, administering radiopharmaceuticals to
humans, positioning of patients for examinations which require the
administration of radiopharmaceuticals to humans, setting technical
factors for examinations which require the administration of radiopharmaceuticals
to humans, operating imaging and/or measuring equipment for examinations
which require the administration of radiopharmaceuticals to humans,
or acquiring and manipulating patient data, other than demographic
and clinical data, with or without the use of computers for procedures
requiring the administration of radiopharmaceuticals.
"Probationary
Approval" means approval which may be awarded by the Department
to a school of nuclear medicine technology which is not in full compliance
with N.J.A.C. 7:28-24.10 and 11but which has entered into a written
agreement, approved by the Commission, to correct the item(s) of non-compliance.
"Provisional
Approval" means approval which may be awarded by the Department
to a new school of nuclear medicine technology which, upon review
by the Commission of an application and self-study document, is found
to be in compliance with N.J.A.C. 7:28-24.10 and 11. Provisional approval
may be awarded to a new school of nuclear medicine technology prior
to an on-site evaluation of its program.
"Radionuclide"
means a radioactive element or a radioactive isotope.
"Radiopharmaceutical"
means a radionuclide or radionuclide compound designed and prepared
for administration to humans.
"Supervision"
means guidance and instruction.
"Temporary
License" means a license which has been issued by the Department
to an individual to act as a nuclear medicine technologist for a limited
period of time.
"Therapeutic
dose" means a radionuclide or radiopharmaceutical which is intended
for therapeutic purposes.
(b)
Definitions for other terms used in this subchapter may be found in
subchapter 1 of this chapter.
7:28-24.3 General provisions
(a) No owner, authorized medical
user, person or business shall cause, allow or permit any other person
to prepare or administer radiopharmaceuticals or to otherwise engage
in the practice of nuclear medicine technology or to act as a licensed
nuclear medicine technologist unless that other person is an authorized
medical user or possesses a current, validly obtained license as a
nuclear medicine technologist, pursuant to this subchapter.
(b) No person shall prepare
or administer radiopharmaceuticals or otherwise engage in the practice
of nuclear medicine technology or act as a licensed nuclear medicine
technologist unless such person is an authorized medical user or possesses
a current, validly obtained license as a nuclear medicine technologist,
pursuant to this subchapter.
(c) No person shall use sealed
sources composed of radionuclides for purposes of radiotherapy, except
for an authorized medical user or a radiation therapy technologist
as licensed pursuant to N.J.S.A. 26:2D-24 et seq. and N.J.A.C. 7:28-19.
(d) No licensed nuclear medicine
technologist or other person, except for an authorized medical user,
shall:
1. Prescribe, determine
the dosage for, or order the administration of any form of radionuclides
to a human being; or
2. Apply, administer, determine
the dosage for, or order the administration of therapeutic doses
of any form of radionuclides to a human being.
(e) Subsection (d) above shall
not be interpreted as precluding a licensed physician or any other
medical professional authorized by their licensing agency from requesting
a diagnostic or therapeutic procedure for a human being.
(f) Under the direction of
a licensed physician, a licensed nuclear medicine technologist may
administer pharmaceuticals provided that the New Jersey State
Board of Medical Examiners has authorized the administration of the
pharmaceutical through the promulgation of rules at N.J.A.C. 13:35
or the adoption of policy. Any inquiry about the authority to administer
a specific pharmaceutical should be directed to the Board of Medical
Examiners.
(g) The owner, the registrant,
and the holder of a Federal or State license for radioactive materials
shall be jointly and severally responsible for identifying and documenting
the identity of an authorized medical user for each administration
of that radiopharmaceutical. Such authorized medical user shall be
responsible for any administration of such radiopharmaceutical by
a licensed nuclear medicine technologist.
(h) The authorized medical
user, the owner, the registrant, the holder of a Federal or State
license for radioactive materials, and the licensed nuclear medicine
technologist, shall be jointly and severally responsible for complying
with all license conditions including but not limited to recording
such information as may be required as a condition of registration
or license issued pursuant to this chapter.
(I) For each administration
of a radiopharmaceutical, the authorized medical user, owner, registrant,
and licensed nuclear medicine technologist shall be jointly and severally
responsible for recording the following information:
1. Generic name, trade
name, or standard addreviation of the radiopharmaceutical, its
lot number and its expiration date, and the radionuclide;
2. Patient's or human research
subject's name, and identification number if one has been assigned;
3. Prescribed dosage and
activity of the dosage at the time of measurement, or a notation
that the total activity is less than 30 microcuries;
4 Date and time of the
measurement;
5. Date and time of administration;
6. Initials of the individual
who made the record; and
7. The name of the identified
authorized medical user.
(j) A licensed nuclear medicine
technologist shall carry out the practice of nuclear medicine technology
in a manner consistent with any applicable State or Federal license
conditions.
(k) No person shall:
1. Engage in the use or
employment of dishonesty, fraud, deception, misrepresentation,
false promise or false pretense while engaged in activities relating
to nuclear medicine technology or obtaining a nuclear medicine
technology license; or
2. Falsify or make misleading
statements on any application for examination or license; or
3. Make misleading or false
statements to a representative of the Department or Commission;
or
4. Alter any license or
examination results; or
5. Fail to comply with
any provision of the Act or any rules or regulations promulgated
thereunder; or
6. Engage in the practice
of nuclear medicine technology while in an intoxicated state or
under the influence of narcotics or any drugs which impair or
tend to impair consciousness, judgment or behavior; or
7. Engage in negligence,malpractice
or incompetence while practicing nuclear medicine technology;
or
8. Falsify any records,
or destroy or steal property or records, relating to the practice
of nuclear medicine technology; or
9. Fail to exercise due
regard for safety, life or health while engaged in the practice
of nuclear medicine technology; or
10. Violate any condition
of a New Jersey radioactive materials license issued pursuant
to N.J.A.C. 7:28; or
11. Violate any condition
and restriction that the Department has placed on his/her nuclear
medicine technology license; or
12. Fail to display immediately
his or her nuclear medicine technology license, or a true copy
thereof, upon request of the Department, employer or any patient.
(l) Any authorized medical
user or licensed nuclear medicine technologist who directly supervises
another individual engaging in the practice of nuclear medicine technology
shall be personally aware of, and maintain any other legal
responsibility for, the procedure intended for a given patient, and
shall be present in the facility and available for immediate assistance.
7:28-24.4 Examination for licensure
of nuclear medicine technologists
(a) Subject to (b) below, the
Department shall admit to examination for licensure any applicant
who has paid a fee to the Department as specified in N.J.A.C. 7:28-24.8
and submitted satisfactory evidence, verified by oath or affirmation,
that the applicant:
1. At the time of application
is at least 18 years of age; and
2. Has successfully completed
four years of secondary school or approved equivalent, at a duly
accredited educational institution; and
3. Has successfully completed
either a course of study in nuclear medicine technology approved
by the Department or an equivalent course of study as determined
by the Department, upon the recommendation of the Commission.
(b) The Department may deny
an examination application if the applicant has committed any act
or omission specified at N.J.A.C. 7:28-24.9(a).
(c) An applicant who fails
to pass the examination may reapply in accordance with this section.
(d) Examinations shall be scheduled
at the discretion of the Department.
7:28-24.5
Nuclear medicine technologist licenses
(a) The Department may issue
a license to any applicant who is at least 18 years of age and has
paid a fee to the Department as specified in N.J.A.C. 7:28-24.8 and
who has submitted satisfactory evidence, verified by oath or affirmation,
that the applicant:
1. Has within three years
of the date of application for a license passed a nuclear medicine
technology licensing examination approved by the Commission; or
2. Has within three years
of the date of application passed a nuclear medicine technology
examination administered by the American Registry of Radiologic
Technologists, Nuclear Medicine Technology Certification Board
or American Society of Clinical Pathologists, or another examination
approved by the Commission; or
3. Holds a current certificate,
registration, or license as a nuclear medicine technologist issued
by another state or country or by any of the organizations named
in N.J.A.C. 7:28-24.5(a)2 and has engaged in the practice of nuclear
medicine technology for at least 1,000 hours during the preceding
three years in a manner consistent with this chapter; however,
such acceptance shall be conditioned upon the certification, registration
or licensure standards in the other state or country being equivalent
and satisfactory to the Commission; or
4. Has passed, more than
three years prior to the application for a license, a nuclear
medicine technology examination approved by the Commission, and
has legally engaged in the practice of nuclear medicine technology
for at least 1,000 hours during the three years preceding the
application for a license in a manner consistent with this chapter.
(b) The Department may deny
a license application if the applicant has committed any act or omission
specified at N.J.A.C. 7:28-24.9(a).
7:28-24.6 Temporary, conditional
and restricted licenses
(a) The Department may issue
a temporary license to any person who has graduated from a nuclear
medicine technology educational program approved by the Department
pursuant to N.J.A.C. 7:28-24.11. A temporary license shall be issued
only if the Department finds that its issuance will not violate the
purposes of the Act or tend to endanger public health and safety.
(b) A temporary license shall
expire 60 calendar days after the date of graduation. A single 30
calendar day extension may be granted provided that the applicant
has taken an approved licensing examination and is awaiting the results
of the examination.
(c) The Department, at its
discretion, may issue a conditional or restricted license including,
but not limited to, a condition or restriction limiting the scope
of practice of a licensed nuclear medicine technologist.
(d) No person who possesses
a conditional or restricted license shall practice outside of the
conditions or restrictions as listed on the license.
7:28-24.7 License expiration and
license renewal
(a) No nuclear medicine technologist
shall practice without a valid New Jersey nuclear medicine technology
license.
(b) A nuclear medicine technologist
shall inform the Department of any change in the address of
record within 30 calendar days of the change.
(c) In order to maintain a
valid license, a nuclear medicine technologist shall renew his/her
license biennially by submitting a renewal application for a nuclear
medicine technology license and the required renewal fee specified
in N.J.A.C. 7:28-24.8.
(d) Each license expires on
December 31 of the first even numbered year following the year of
its issuance. A license may be renewed for a biennial term commencing
January 1 of every odd numbered year and expiring on December 31 of
the following year.
(e) A nuclear medicine technologist
who possesses an expired license may renew the license, provided that
the license has not been expired for more than three years. An individual
who wishes to renew an expired license shall submit a renewal application
and the current renewal fee to the Department. Such licenses shall
be renewed for a period extending from date of renewal to midnight,
December 31 of the next even numbered year.
(f) A nuclear medicine technologist
who possesses a license which has been expired for more than three
years may not have that license renewed, but may apply for a new license
through re-examination and other applicable requirements for initial
license applications at N.J.A.C. 7:28-24.4 or, if applicable, at N.J.A.C.
7:28-24.5.
7:28-24.8
Fees
(a) Any person who submits an
application for an examination, license, or license renewal to the
Department shall include as an integral part of the application a
service fee as follows:
1. Examination Application
Fee: $75.00
2. Initial License Application
Fee: $40.00;
3. Biennial License Renewal
Fee: $40.00.
(b) All fees shall be in the form
of a check or money order made payable to the Treasurer, State of
New Jersey.
1. The fees submitted to the
Department are not refundable.
2. All examination and initial
license applications and associated fees shall be mailed to:
State of New Jersey
Department of Environmental Protection
Bureau of Radiological Health
PO Box 415
Trenton, New Jersey 08625-0415
3. All biennial license renewal
applications and associated fee shall be mailed to:
State of New Jersey
Department of Treasury
Division of Revenue
PO Box 417
Trenton, New Jersey 08625-0417
7:28-24.9 Examination application
or license application denial, license revocation and suspension
(a) The Department,
in addition to any penalties authorized by the Act, may deny any examination
or license application, and may revoke or suspend a nuclear medicine
technology license, when the applicant or licensed nuclear medicine
technologist has:
1. Violated
any of the provisions contained in N.J.A.C. 7:28-24.3(b), (c),
(d), (f), (h), (i), (j), (k), or (l), or
2. Been convicted of, any
crime which relates, or could relate, adversely to the practice
of nuclear medicine technology. For the purpose of this section,
a plea of guilty, non vult, no contest, or any other such disposition
of alleged criminal activity shall be deemed a conviction, or
3. Has been admitted to a
pre-trial intervention program or the substantial equivalent thereof
based upon alleged conduct which relates, or could relate, adversely
to the practice of nuclear medicine technology, or
4. Has had his/her certification,
registration, or license to practice nuclear medicine technology
revoked or suspended by any other state or certifying agency for
reasons consistent with this chapter, or
5. Is incapable, for medical
or any other good cause, of discharging the functions of a licensee
in a manner consistent with the health, safety and welfare of
the public.
(b) Any revocation or suspension
issued pursuant to this section shall be in accordance with the following:
1. Revocation or suspension
of a nuclear medicine technologist's license shall be initiated
by the Department through issuance of a Notice of Revocation or
Notice of Suspension. The Notice shall include the findings of
the Department upon which the revocation or suspension is based.
The Notice shall also include the date upon which the revocation
or suspension shall become effective. The Notice may be accompanied
by an Order requiring compliance with the Radiation Protection
Act, N.J.S.A. 26:2D-1 et seq. or any rule promulgated pursuant
thereto. Within 20 days of delivery of the Notice, an individual
whose license is to be revoked or suspended may deliver to the
Commissioner a written request for an administrative hearing,
pursuant to the Administrative Procedure Act, N.J.S.A. 52:14B-1
et seq., to contest such revocation or suspension. The individual's
request for an administrative hearing shall include a written
statement of all issues of fact or law contained within the Notice
which are disputed by the individual.
2. If the Commissioner determines
the matter to be a contested case, he shall refer the matter
to the Office of Administrative Law for hearing before an administrative
law judge, pursuant to the Administrative Procedure Act. Upon
review of the record of the administrative hearing in contested
cases the Commissioner may affirm, modify or reject the Initial
Decision of the administrative law judge and/or the findings
of the Department. If the Commissioner finds that the charges
in a contested case have not been proven, he shall order them
dismissed. If the Department's findings are found to be true,
the Commissioner may, in his discretion, issue an order suspending
or revoking the license of the individual. In uncontested cases,
the revocation or suspension of the individual's license shall
be effective as of the date specified in the Notice of Revocation
or Notice of Suspension.
(c) This subchapter shall not
in any way affect or abridge the powers of the Department to issue
emergency orders pursuant to N.J.S.A. 26:2D-12 or to bring an action
in Superior Court, pursuant to N.J.S.A. 26:2D-13).
7:28-24.10 School of nuclear
medicine technology: standards for approval
(a) A school of nuclear medicine
technology shall be approved by the Department if:
1. The curriculum includes
the following minimum content areas or prerequisites:
i. Basic anatomy, physiology,
and pathology;
ii. Intravenous injections,
both direct and peripheral, and other methods shall include
but not limited to, into existing urinary catheters (indwelling
and other), into existing nasogastric tubes or other gastric
or intestinal feeding tubes, into existing central intravenous
lines, through existing spinal needles placed into
the subarachnoid space;
iii. Radiation physics
and nuclear medicine physics;
iv. Radionuclide chemistry
and pharmacology to include adverse reactions to radiopharmaceuticals
and other pharmaceuticals used in nuclear medicine;
v. Statistics;
vi. Nuclear medicine departmental
organization and function;
vii. Nuclear instrumentation;
viii. Radiation biology;
ix. Radionuclide therapy;
x. Radiation safety and
radiation protection standards and codes;
xi. Laboratory procedures
and techniques;
xii. Clinical application
of radionuclides, for both diagnostic and therapeutic purposes;
xiii. Records and administrative
procedures;
xiv. Methods of patient
care;
xv. Medical law and ethics;
xvi. Computer applications;
xvii. Quality assurance;
and
xviii. State and Federal
regulations
2. The curriculum includes
a valid plan for well-structured competency-based clinical education.
3. The school of nuclear medicine
technology additionally complies with the Essentials and Guidelines
of an Accredited Educational Program for the Nuclear Medicine
Technologist (1997), which have been jointly adopted, jointly
revised and published by the American College of Radiology, American
Society of Radiologic Technologists, Society of Nuclear Medicine
and Society of Nuclear Medicine - Technologist Section or their
successors. These Essentials and Guidelines are incorporated into
this rule by reference herein, as amended and supplemented, and
may be obtained by contacting the Department.
7:28-24.11 School of nuclear
medicine technology: process for approval; provisional approval; probationary
approval; withdraw of approval and other general provisions
(a) The Department, upon the
recommendation of the Commission, shall approve a school of nuclear
medicine technology if it has been determined that the school has
complied with the requirements of this subchapter.
(b) In order to become an approved
school, a school of nuclear medicine technology shall apply to the
Department. Along with the application, a school of nuclear medicine
technology applying for approval shall also submit to the Department
a self-study document which shall include, but is not limited to,
information regarding the school's instructional curriculum, faculty,
classroom and clinical facilities, student policies and administrative
organization. After review of the school's application and self-study
document and a determination that the school substantially meets
the standards set forth in this subchapter, the Department, upon
the recommendation of the Commission, may provisionally approve
the school. When the Department has determined that the school is
in full compliance with the requirements of this subchapter, full
approval may be issued.
(c) No school of nuclear medicine
technology shall enroll students until provisional approval has
been received from the Department.
(d) No school shall hold itself
out to be an approved school of nuclear medicine technology until
the school is approved by the Department.
(e) Upon the request of the
Department and/or Commission, a school of nuclear medicine technology
or its affiliates shall:
1. Demonstrate, to the satisfaction
of the Department and/or Commission, that it complies with the
requirements of this subchapter;
2. Permit an appointee of
the Commission and/or an employee of the Department to conduct
a site inspection. The Department, upon the recommendation of
the Commission, may accept a site inspection or accreditation
by a national accreditation agency recognized by the Commission;
and
3. Make available to the
Department and/or Commission such information or records as
the Department or Commission, or their representatives, shall
request.
(f) The Department, upon the
recommendation of the Commission, may reduce the status of a school
of nuclear medicine technology's approval to probationary approval
for failure to comply with the provisions contained in this subchapter.
A school on probationary approval shall:
1. Within a period of time
determined by the Department, correct all specified deficiencies
contained in a written agreement approved by the Department
as recommended by the Commission; and
2. Within 15 calendar days
of receipt of notification, notify all enrolled students and
all applicants via certified mail of the school's probationary
approval status; and
3. Within 15 calendar days
of receipt of notification, submit to the Department a copy
of the probationary notice supplied to students.
(g) Any school of nuclear medicine
technology subject to this subchapter shall:
1. Prepare and maintain
a current and accurate written course syllabus for each content
area delineated in N.J.A.C. 7:28-24.10(a). These documents shall
include, but are not limited to: lesson plans, learning objectives,
classroom schedules, and the student evaluation instruments.
These documents shall be on file at the school and shall be
produced for review by the Department or its representative
during an inspection and shall be submitted to the Department
upon request.
2. Issue to each candidate
prior to admission a course catalog, bulletin, or other written
statement which shall be currently dated and include a description
of the curriculum as a whole, course descriptions, and information
concerning amounts and terms for payment of any tuition or other
fees or expenses to be incurred. The information contained in
these documents shall accurately reflect the program being offered.
3. Report in writing to
the Department, within 30 calendar days of any student's matriculation
date, the name and address of each new student enrolled and,
within 30 calendar days of any student's completion date, the
name and address of each student who has successfully completed
the course of study.
4.
Assign students only to clinical affiliates which have been approved
by the Department, upon the recommendation of the Commission.
5.
Ensure that, while assigned to clinical education, students shall
have on their person visible identification name badges which
indicate that they are student nuclear medicine technologists.
6.
Have and adhere to an educational plan for clinical assignments
with clinical objectives relating to the practice of nuclear medicine
technology. Students shall not take the responsibility or the
place of licensed nuclear medicine technologists.
7. Ensure that prior to
a student's demonstration of clinical competency in a given nuclear
medicine technology activity that the activity is performed with
immediate supervision. After clinical competency in the activity
has been determined, the activity may be performed under direct
supervision.
8. Ensure that
radiation monitoring devices are worn by students, while assigned
to any controlled area.
9. Ensure that all students
are provided with whole body and finger radiation monitoring
devices, during their period of attendance. Student exposure to
radiation shall not exceed the occupational limits prescribed
in N.J.A.C. 7:28. Within 30 days of the school's receipt of the
radiation dosimetry report, the school shall inform all students
of their most recent exposure readings. In the event that a student
receives a high exposure reading, the school shall begin an investigation
within 14 days of the school's receipt of a high exposure reading
to find the cause and prevent recurrence of exposure which is
deemed to be unnecessary. The results of this investigation and
any action taken by the school shall be maintained in the student's
file. Within 90 calendar days of departure from the school, students
shall be provided with a record of their exposure history.
10. Inform the Department
within 30 calendar days of any change that could adversely affect
the program's ability to fulfill its commitment to students or
has altered how the program operates since its last review and
approval by the Department. Such changes include but are not limited
to: a change in any program official or faculty member, curriculum,
loss of a clinical affiliate, the sequencing of courses, length
of the program, sponsorship of the program.
11. Continue
to comply with all standards for approval in N.J.A.C. 7:28-24.10.
(h) A school
of nuclear medicine technology may have its approval, provisional
approval and/or probationary approval denied or withdrawn by the Department,
upon the recommendation of the Commission, for failure to continue
to comply with all provisions of this subchapter.
(i) The Department
shall notify a school of nuclear medicine technology, by certified
mail, of any violation or deficiency resulting in denial, withdraw,
or withholding of approval or a change in approval status.
(j) The effective date of any
notice issued pursuant to N.J.A.C. 7:28-24.11(f) or (h) shall be 20
days following receipt of the Department's notice, unless otherwise
stated in the notice.
(k)
A school of nuclear medicine technology's approval may be terminated
if the school does not have any students enrolled for a period of
two successive years.
(l)
A school of nuclear medicine technology whose approval has been terminated
or has been withdrawn may apply for approval as a new school of nuclear
medicine technology as provided at N.J.A.C. 7:28-24.11.
7:28-24.12 List of approved schools
A list of approved schools
of nuclear medicine technology and their approval status shall be
available from the Department, and may be obtained by contacting the
Department. (See N.J.A.C. 7:28-24.8(b) 2 for the Department's address)
|